Home page hero image

Imagine...

a world where new therapies can be discovered and developed in a fraction of what it takes now.

How can we help?

Drug Discovery

The Cytocast Digital Twin Cell™ is an innovative platform designed to predict drug side effects by simulating billions of molecular interactions within human cells. Relying on a wide range of available information on how complex cellular processes work, our solution has the potential to revolutionize drug discovery by accelerating the overall process, reducing costs, and increasing clinical trial success rates. 
Cytocast Digital Twin Cell™

Precision medicine

Cytocast Digital Twin Patient™ technology is currently in development at Cytocast. It is poised to play a pivotal role in enabling data-driven, personalized care that tailors treatments to patients based on their distinctive molecular characteristics, covering a wide range of therapeutic domains. Our approach to precision medicine development leverages multi-omics, single-cell, and patient data to gain a comprehensive understanding of how perturbations, such as diseases or drugs, impact cellular health in a personalized manner.
Cytocast Digital Twin Patient™

People and Values

Cytocast is an emerging TechBio startup based in Budapest that specializes in data-driven medical technology. We leverage this data to add value and achieve impactful results.

People of Cytocast

OUR VALUES

We are proud to be a company with a curious mindset and a strong research orientation. What sets us apart is the way we integrate multi-omics data, extensive scientific knowledge, expertise, high-performance computing, and cutting-edge data science methods to maximize insights into patient biology and accelerate the pace of drug discovery and development. We also have the privilege of working with numerous collaborative partners. We value these partnerships and recognize their importance in advancing our mission.

MAKE MEDICINE BETTER WITH ADVANCED CELL SIMULATION TECHNOLOGY 

People of Cytocast

THE TEAM

At Cytocast, we believe in creative solutions and in the power of teamwork in a familiar atmosphere. Many of our team members have university affiliations continually exploring new possibilities.   

How we do it

Cytocast is using computer simulations to determine the most effective treatment for patients while minimazing potential side effects

0

Proteins per simulation

0

Protein-protein interactions

0

Binding sites per simulation

0

Nr. of cell types

News

Best Solution in the Digital Therapy - 4th Digital Summit Award

Best Solution in the Digital Therapy - 4th Digital Summit Award

2023-12-08

Last week, we had the pleasure of presenting Cytocast's cutting-edge technology at the 4th Digital Health Summit as the Best Solution in the Digital Therapy category winner.

Read more
Cytocast Secures 1.65M Euros in Second Investment Round to Accelerate Innovation and Growth

Cytocast Secures 1.65M Euros in Second Investment Round to Accelerate Innovation and Growth

2023-08-01

We are thrilled to announce that we have successfully secured our second investment round...

Read more
Cytocast at the Hungarian Molecular Life Science Conference 

Cytocast at the Hungarian Molecular Life Science Conference 

2023-03-27

Cytocast team recently participated in the Hungarian Molecular Life Science Conference held in Eger. The conference...

Read more

Blog

Virtual pathways to cures: the future of cellular modeling in pharmaceuticals 

Virtual pathways to cures: the future of cellular modeling in pharmaceuticals 

Cytocast’s dedication to science-driven solutions reflects a significant shift in the healthcare landscape, where computational modeling and simulations are becoming indispensable tools in the quest for faster, safer, and more effective medical treatments

Read more
Cytocast Q2-Q3 2024: Innovations in digital twin technology, simulations and predictions  

Cytocast Q2-Q3 2024: Innovations in digital twin technology, simulations and predictions  

2024-10-04

Cytocast  has made significant strides during the second quarter of 2024, advancing its cutting-edge technology in the field of digital twin simulations and predictive algorithms.

Read more
The Transformative Role of AI in Drug Discovery and Development: A Cytocast Perspective

The Transformative Role of AI in Drug Discovery and Development: A Cytocast Perspective

2023-12-05

Cytocast, at the forefront of innovation, utilizes AI in the Cytocast Simulated Cell to model drug-target interactions, predict efficacy, and identify potential side effects early in drug development. Our commitment extends to ethical considerations, ensuring responsible AI use in shaping the future of drug discovery.

Read more

Interested in a demo?

Get in touch today to see how the Cytocast Digital Twin™ platform works.

Contact us
Szechenyi 2020